Clinical Trial Update: PET Study in Parkinson's Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 PET imaging study in Parkinson's disease patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: AstraZeneca | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED